Jose A. Rinck
Sao Paulo, SP 01509010, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prospective evaluation of 18F-PSMA-1007 PET/CT in renal masses paired with PSMA immunohistochemistry.
Journal: Annals of nuclear medicine
Published: March 02, 2026
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Journal: Cancer immunology, immunotherapy : CII
Published: February 05, 2024
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: May 04, 2023
"Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil".
Journal: Clinical genitourinary cancer
Published: May 09, 2022
Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
Journal: JCO global oncology
Published: April 15, 2021
Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries.
Journal: JCO global oncology
Published: April 15, 2021
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
Journal: Journal of cancer research and clinical oncology
Published: March 30, 2020
Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery.
Journal: Therapeutic advances in urology
Published: May 30, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026